Topolive 2.5 mg Injection 2.5 ml

Topolive 2.5 mg Injection 2.5 ml belongs to a group of medicines called 'anti-cancer/anti-neoplastic agents', used to treat ovarian and small cell lung cancer. On the other hand, it may use to treat advanced cervical cancer if surgery or radiotherapy treatment is not possible. It may sometimes be used to treat other cancers. Ovarian cancer begins in the ovaries (a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the lung tissues.

Topolive 2.5 mg Injection 2.5 ml contains 'Topotecan'. It works by penetrating into the cell wall and binding to the cell's DNA, stopping it from naturally dividing and functioning, ultimately destroying it. These medicines target cancer cells because they often affect rapidly dividing cells.

The amount of medicine that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule. Topolive 2.5 mg Injection 2.5 ml is prescribed by a doctor experienced in the use of medications to treat cancer. You may sometimes experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses, and electrolyte disturbances. Most of these side effects of Topolive 2.5 mg Injection 2.5 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually, continue taking Topolive 2.5 mg Injection 2.5 ml for as long as your doctor has prescribed. Do not stop using the Topolive 2.5 mg Injection 2.5 ml midway. Talk to your doctor before taking Topolive 2.5 mg Injection 2.5 ml if you have severe allergic reactions to Topolive 2.5 mg Injection 2.5 ml or other medicines or suffer from severe lung problems, Infections, renal dysfunction, hepatic disorders and blood cell counts are too low. Avoid taking Topolive 2.5 mg Injection 2.5 ml if you are pregnant or breastfeeding because this Topolive 2.5 mg Injection 2.5 ml can cause harmful effects on the unborn baby. Both women and men using this Topolive 2.5 mg Injection 2.5 ml should use birth control to avoid pregnancy.

Topolive 2.5 mg Injection 2.5 ml contains 'Topotecan', which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or together with other chemotherapy drugs depending on the type of cancer you have.

Topolive 2.5 mg Injection 2.5 ml will be administered by a healthcare professional. To treat your condition effectually, continue taking Topolive 2.5 mg Injection 2.5 ml for as long as your doctor has prescribed. Do not stop Topolive 2.5 mg Injection 2.5 ml midway. Talk to your doctor before taking Topolive 2.5 mg Injection 2.5 ml if you have severe allergic reactions to Topolive 2.5 mg Injection 2.5 ml or other medicines or suffer from severe lung problems, Infections, renal dysfunction, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), hepatic disorders. Topolive 2.5 mg Injection 2.5 ml should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Topolive 2.5 mg Injection 2.5 ml if you are pregnant or breastfeeding because this Topolive 2.5 mg Injection 2.5 ml can cause harmful effects on the unborn baby. Both women and men using this Topolive 2.5 mg Injection 2.5 ml should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during Topolive 2.5 mg Injection 2.5 ml treatment and appropriate until recovery is achieved. Do not receive any kind of immunization or vaccination without your doctor's approval while taking the Topolive 2.5 mg Injection 2.5 ml.